World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
22574
World Ranking
2384
National Ranking
1141

Hans Schreiber publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hans Schreiber sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 212 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hans Schreiber D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hans Schreiber sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hans Schreiber is affiliated with the University of Chicago in the United States. Their research spans several fields, primarily focused on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. The more specific subfields of their work include Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Biotechnology.

The scientist's work predominantly addresses topics related to CAR-T cell therapy research, immunotherapy and immune responses, monoclonal and polyclonal antibodies research, cancer research and treatments, virus-based gene therapy research, nanowire synthesis and applications, and cancer immunotherapy and biomarkers.

Hans Schreiber has contributed to various peer-reviewed journals with frequent publications in the Journal for ImmunoTherapy of Cancer and Cancer Research, as well as individual contributions to Proceedings of the National Academy of Sciences, Human Gene Therapy, and Matter.

Representative recent papers authored or co-authored by Hans Schreiber include:

  • "Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides," 2020, Proceedings of the National Academy of Sciences
  • "LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models," 2020, Human Gene Therapy
  • "Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents," 2021, Matter
  • "Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens," 2020, Carcinogenesis
  • "One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication," 2024, Clinical Cancer Research

The scientist collaborates frequently with other researchers. Notable frequent co-authors include Steven P. Wolf, Karin Schreiber, Kazuma Kiyotani, Matthias Leisegang, and Vasiliki Anastasopoulou.

Best Publications

  • Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski;Hans Schreiber;Yang Xin Fu

  • The terminology issue for myeloid-derived suppressor cells.

    Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo

  • Inflammation as a tumor promoter in cancer induction.

    Mary Philip;Donald A. Rowley;Hans Schreiber

  • Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

    Ping Yu;Youjin Lee;Wenhua Liu;Thomas Krausz

  • Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

    Avery D. Posey;Robert D. Schwab;Alina C. Boesteanu;Catharina Steentoft

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

    Markus Gerhard;Hartmut Juhl;Holger Kalthoff;Hans W. Schreiber

  • A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

    G Torre-Amione;R D Beauchamp;H Koeppen;B H Park

  • CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

    Dominik Mumberg;Paul A. Monach;Sherry Wanderling;Mary Philip

  • Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

    J L Urban;H M Shepard;J L Rothstein;B J Sugarman

  • Inhibition of tumor growth by elimination of granulocytes.

    Lisa A. Pekarek;Barbara A. Starr;Alicia Y. Toledano;Hans Schreiber

  • Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

    Bin Zhang;Natalie A. Bowerman;Joseph K. Salama;Hank Schmidt

  • Priming of naive T cells inside tumors leads to eradication of established tumors

    Ping Yu;Youjin Lee;Wenhua Liu;Robert K. Chin

  • Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.

    Jay L. Rothstein;Hans Schreiber

  • A unique tumor antigen produced by a single amino acid substitution.

    Paul A. Monach;Stephen C. Meredith;Christopher T.Siegel;Hans Schreiber

  • Bystander elimination of antigen loss variants in established tumors.

    Michael T Spiotto;Donald A Rowley;Hans Schreiber

  • Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.

    Michael T. Spiotto;Ping Yu;Donald A. Rowley;Michael I. Nishimura

  • Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.

    Maresa Wick;Purnima Dubey;Hartmut Koeppen;Christopher T. Siegel

  • Tumour ischaemia by interferon-γ resembles physiological blood vessel regression

    Thomas Kammertoens;Christian Friese;Christian Friese;Ainhoa Arina;Christian Idel

  • Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism

    Elena Loukinova;Gang Dong;Ileana Enamorado-Ayalya;Giovana R Thomas

Frequent Co-Authors

David M. Kranz
David M. Kranz University of Illinois at Urbana-Champaign
Yang-Xin Fu
Yang-Xin Fu Tsinghua University
Hans J. Stauss
Hans J. Stauss University College London
Ralph R. Weichselbaum
Ralph R. Weichselbaum University of Chicago
Stephen C. Meredith
Stephen C. Meredith University of Chicago
Theodore Karrison
Theodore Karrison University of Chicago
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
W. Martin Kast
W. Martin Kast University of Southern California
Henrik Clausen
Henrik Clausen University of Copenhagen
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare professions, particularly nursing. For those interested in advancing their clinical roles, exploring the cheapest pmhnp certificate programs can be a strategic pathway to specialize in psychiatric mental health alongside immunological studies.

Nurses aiming to expand their expertise might consider online programs designed to fast-track their career, such as the accelerated fnp programs, which help Family Nurse Practitioners gain advanced knowledge efficiently. Additionally, transitioning roles within nursing specializations is facilitated by options like the fnp to acnp bridge program online, offering a flexible path to acute care expertise that complements immunology-related clinical skills.

Understanding the financial outlook is also crucial. For instance, the dnp salary by specialty provides insight into how pursuing different nursing and healthcare degrees can impact long-term earning potential. This information helps prospective students align their educational investments with desired career outcomes in the health sciences.

Best Scientists Citing Hans Schreiber

Trending Scientists

Recently Published Articles